Small text size Medium text size Large text size Email Print Select Country Algeria Argentina Australia Austria Belgium Brazil Bulgaria Canada China Colombia Costa Rica Czech Republic Denmark Dominican Republic Ecuador Egypt Estonia Finland France Germany Greece Guatemala Hong Kong Hungary India Indonesia Israel Italy Japan Jordan Kazakhstan Korea Latvia Lebanon Lithuania Malaysia Mexico Morocco Netherlands Norway Pakistan Panama Philippines Poland Portugal Reunion Romania Russia Senegal Serbia Singapore Slovakia Slovenia South Africa Spain Sweden Switzerland Taiwan Thailand Tunisia Turkey – PHILSA Turkey – PMSA Ukraine United Arab Emirates United Kingdom and Ireland Venezuela Vietnam PMI Around the World Sweden EN SV Contact Us Philip Morris AB Karlavägen 108 104 51 Stockholm Sweden Tel: +46 8440 59 40 Careers Digital Project Leader Sweden Date:February 23, 2016 International Opportunities Country Overview Key Facts Number of Employees: Approximately 130 Main Brands: Marlboro, L&M, Chesterfield Welcome to Philip Morris Sweden. We were established in 1969 and are now one of the leading tobacco companies in the country, employing approximately 130 people. Our main brands include Marlboro, L&M, and Chesterfield. In addition to cigarettes, we also sell rolling tobacco. Smoking and Health Tobacco products, including cigarettes, are dangerous and addictive. There is overwhelming medical and scientific evidence that smoking causes lung cancer, heart disease, emphysema, and other serious diseases. Addiction All tobacco products are addictive. It can be very difficult to quit smoking, but this should not deter smokers who want to quit from trying to do so. Secondhand Smoke Public health officials have concluded that secondhand smoke from cigarettes causes serious diseases in non-smokers, including lung cancer and heart disease. We believe the public health conclusions on secondhand smoke are sufficient to support smoking restrictions in public places. Effective Regulation Philip Morris International (PMI) supports comprehensive regulation of tobacco products based on the principle of harm reduction. To be effective, tobacco regulatory policy must be evidence-based, apply to all tobacco products, and should take into account the views of all legitimate stakeholders including public health authorities, government finance authorities, tobacco manufacturers, and other members of the tobacco supply chain. Regulatory policy must consider the potential to trigger adverse consequences which undermine public health objectives, such as increasing the demand for illicit cigarettes. While we support comprehensive, effective tobacco regulation, we do not support regulation that prevents adults from buying and using tobacco products or that imposes unnecessary impediments to the operation of the legitimate tobacco market. In that regard, we oppose measures such as generic packaging, point of sale display bans, total bans on communications to adult consumers, and bans on the use of all ingredients in tobacco products. © 2002-2021 Philip Morris International Management SA | Company Information We do this to remember your preferences and compile analytics of visits. By using our site, you agree to our use of all cookies. Otherwise, to find out more and set your preferences, please go to our Cookie Notice. Set cookie preferences